Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer-Reference-Cited by-全球学者库

Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer

Published:2018-01-30 Issue:4 Volume:57 Page:211-220
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Liu Liping¹²,Liu Han³^ORCID,Shao Di³⁴⁵^ORCID,Liu Zu³,Wang Jingjing³,Deng Qiuhua¹²,Tang Hailing¹²,Yang Haihong⁶,Zhang Yalei⁶,Qiu Yuan⁶,Cui Fei⁶,Tan Meihua³⁴,Zhang Pan³,Li Zhilong³,Liu Jilong³,Liang Wenhua¹⁶,Wang Yuying⁴,Peng Zhiyu⁴,Wang Jian⁷⁸,Yang Huanming⁷⁸,Mao Mao⁴,Kristiansen Karsten⁵⁷,Ye Mingzhi³⁴⁵,He Jianxing¹⁶

Affiliation:

1. State Key Laboratory of Respiratory Diseases; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease; Guangzhou 510120 China

2. The Translational Medicine Laboratory; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou 510120 China

3. BGI-Guangzhou Medical Laboratory; BGI-Shenzhen; Guangzhou 510006 China

4. BGI Genomics, BGI-Shenzhen; Shenzhen 518083 China

5. Laboratory of Genomics and Molecular Biomedicine, Department of Biology; University of Copenhagen; Copenhagen DK 2200 Denmark

6. Department of Thoracic Surgery; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou 510120 China

7. BGI-Shenzhen; Shenzhen 518083 China

8. James D. Watson Institute of Genome Sciences; Hangzhou 310058 China

Funder

National Key R&D Program of China

Science and Technology Planning Project of Guangdong Province, People's Republic of China

Science and Technology Planning Project of Guangzhou, People's Republic of China

Guangzhou Health and Medical Collaborative Innovative Major Special Projects

special foundation for High-level Talents of Guangdong

Guangzhou Science and Technology Project

Pearl River Nova Program of Guangzhou

Natural Science Foundation for Distinguished Young Scholars of Guangdong Province

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference31 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin.,2014

2. Epidemiology of lung cancer in China;Chen;Thorac Cancer.,2015

3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med.,2010

4. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations;Sequist;J Clin Oncol.,2013

5. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N Engl J Med.,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actionable mutational profiling in solid tumors using hybrid‐capture‐based next‐generation sequencing in a real‐world setting in Spain;Cancer Medicine;2024-01-11

2. Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis;2023-10-28

3. First Report of Pseudopithomyces palmicola Causing Leaf Spot on Italian Ryegrass in China;Plant Disease;2023-09-01

4. Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results;ESMO Open;2023-08

5. Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-07-06